Nuveen Asset Management, LLC Mei Pharma, Inc. Transaction History

Nuveen Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.42 - $0.65 $151,610 - $234,635	-360,977 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.54 - $2.74 $1,800 - $9,135	3,334 Added 0.93%	360,977 $650,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $85,086 - $123,065	-36,518 Reduced 9.26%	357,643 $835,000
Q3 2021 Nov 12, 2021	BUY	$2.52 - $2.99 $55,623 - $65,998	22,073 Added 5.93%	394,161 $1.06 Million
Q2 2021 Aug 16, 2021	SELL	$2.6 - $3.65 $66,731 - $93,680	-25,666 Reduced 6.45%	372,088 $1.06 Million
Q1 2021 May 17, 2021	SELL	$2.73 - $4.5 $17,862 - $29,443	-6,543 Reduced 1.62%	397,754 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$2.6 - $3.32 $3,299 - $4,213	1,269 Added 0.31%	404,297 $1.07 Million
Q3 2020 Nov 16, 2020	SELL	$2.46 - $4.27 $2.31 Million - $4.01 Million	-938,019 Reduced 69.95%	403,028 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$1.45 - $4.3 $1.65 Million - $4.88 Million	1,135,316 Added 551.84%	1,341,047 $5.54 Million
Q1 2020 May 14, 2020	BUY	$0.75 - $2.55 $24,161 - $82,148	32,215 Added 18.57%	205,731 $331,000
Q4 2019 Feb 14, 2020	SELL	$1.65 - $2.48 $2,831 - $4,255	-1,716 Reduced 0.98%	173,516 $430,000
Q2 2019 Aug 15, 2019	BUY	$2.45 - $3.32 $429,318 - $581,770	175,232 New	175,232 $438,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $370M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.